Actively Recruiting
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Led by Janssen-Cilag Ltd. · Updated on 2026-05-12
200
Participants Needed
1
Research Sites
190 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study aims to assess the 1-year persistence of guselkumab in adult patients with psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches).
CONDITIONS
Official Title
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of psoriatic arthritis by a rheumatologist using CASPAR criteria
- Starting guselkumab as first, second, third, or fourth line bDMARD therapy for psoriatic arthritis
- Guselkumab treatment initiated according to Summary of Product Characteristics (SmPC) guidelines
- Treatment decision made by the rheumatologist before and independent of study inclusion
- Provided oral agreement and has not objected to data collection according to French requirements
You will not qualify if you...
- Previous treatment with a specific interleukin-23 inhibitor
- Receiving combination therapy with two or more targeted therapies for psoriatic arthritis or psoriasis at the same time
- Contraindication to guselkumab per SmPC (e.g., hypersensitivity, active significant infection like tuberculosis)
- Unwilling or unable to participate in long-term data collection
- Received investigational drug or invasive investigational medical device within 30 days before study start
- Currently enrolled in any interventional study or Janssen-Cilag France-sponsored observational study
- Under legal guardianship, curatorship, judicial or family protection mandates
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Roger Salengro - CHU Lille
Lille, France, 59037
Actively Recruiting
Research Team
S
Study Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here